Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Wågberg M"'
Autor:
Tejedor S; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden., Wågberg M; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Correia C; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Åvall K; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Hölttä M; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Hultin L; Imaging and Data Analytics, Clinical and Pharmacological Safety Science, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Lerche M; Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Davies N; Advanced Drug Delivery, Pharmaceutical Science, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Bergenhem N; Alliance Management, Business Development and Licensing, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA 02451, USA., Snijder A; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Marlow T; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Dönnes P; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden.; SciCross AB, 541 35 Skövde, Sweden., Fritsche-Danielson R; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Synnergren J; Systems Biology Research Center, School of Bioscience, University of Skövde, 541 28 Skövde, Sweden.; Department of Molecular and Clinical Medicine, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden., Jennbacken K; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden., Hansson K; Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 431 50 Gothenburg, Sweden.
Publikováno v:
Cells [Cells] 2024 Feb 27; Vol. 13 (5). Date of Electronic Publication: 2024 Feb 27.
Autor:
Alexandersson K; Sundsvall Hospital, County Council of Västernorrland, Sundsvall, Sweden., Wågberg M; Sundsvall Hospital, County Council of Västernorrland, Sundsvall, Sweden., Ekeblad A; Sundsvall Hospital, County Council of Västernorrland, Sundsvall, Sweden.; Department of Behavioural Sciences and Learning, Linköping University, Linkoping, Sweden., Holmqvist R; Department of Behavioural Sciences and Learning, Linköping University, Linkoping, Sweden., Falkenström F; Department of Behavioural Sciences and Learning, Linköping University, Linkoping, Sweden.; Department of Psychology, Linnaeus University, Växjö, Sweden.
Publikováno v:
Psychotherapy research : journal of the Society for Psychotherapy Research [Psychother Res] 2023 Jan; Vol. 33 (1), pp. 57-69. Date of Electronic Publication: 2022 Jan 23.
Autor:
Voronova V; M&S Decisions LLC, Moscow, Russia., Sokolov V; M&S Decisions LLC, Moscow, Russia.; STU Sirius, Sochi, Russia., Morias Y; Bioscience Cardiovascular, Research and Early Development, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, Gothenburg, Sweden., Boezelman MJ; Bioscience Cardiovascular, Research and Early Development, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, Gothenburg, Sweden., Wågberg M; Bioscience Cardiovascular, Research and Early Development, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, Gothenburg, Sweden., Henricsson M; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, Gothenburg, Sweden., Hansson K; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, Gothenburg, Sweden., Goltsov A; M&S Decisions LLC, Moscow, Russia.; Institute for Artificial Intelligence, Russian Technological University (MIREA), Moscow, Russia., Peskov K; M&S Decisions LLC, Moscow, Russia.; STU Sirius, Sochi, Russia.; I.M. Sechenov First Moscow State Medical University, Moscow, Russia., Sundqvist M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceutical R&D AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Nov 28; Vol. 13, pp. 993422. Date of Electronic Publication: 2022 Nov 28 (Print Publication: 2022).
Autor:
Rikard SM; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA USA., Myers PJ; Department of Chemical Engineering, University of Virginia, Charlottesville, VA USA., Almquist J; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Fraunhofer-Chalmers Centre, Chalmers Science Park, Gothenburg, Sweden.; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Bruce AC; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA USA., Wågberg M; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Fritsche-Danielson R; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Hansson KM; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lazzara MJ; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA USA.; Department of Chemical Engineering, University of Virginia, Charlottesville, VA USA., Peirce SM; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA USA.; Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA USA.
Publikováno v:
Cellular and molecular bioengineering [Cell Mol Bioeng] 2021 Jun 15; Vol. 14 (4), pp. 321-338. Date of Electronic Publication: 2021 Jun 15 (Print Publication: 2021).
Autor:
Almquist J; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Fraunhofer-Chalmers Centre, Chalmers Science Park, Gothenburg, Sweden.; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rikard SM; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Wågberg M; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bruce AC; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Integrative Systems Biology, Department of Biomedical Engineering, Linköping University, Linköping, Sweden., Fritsche-Danielson R; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Chien KR; Integrated Cardiometabolic Center, Karolinska Institute, Huddinge, Sweden.; Department of Cell and Molecular Biology and Medicine, Karolinska Institute, Stockholm, Sweden., Peirce SM; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Hansson K; Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lundahl A; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Jul; Vol. 9 (7), pp. 384-394. Date of Electronic Publication: 2020 Jul 05.
Autor:
Liu, Yang1 (AUTHOR), Liang, Jia-Ming1 (AUTHOR), Guo, Guo-Xia1 (AUTHOR), Qiu, Yu-Huan1,2 (AUTHOR), Yu, Le-Le1 (AUTHOR), Tsim, Karl Wah-Keung2,3,4 (AUTHOR), Qin, Qi-Wei1,2 (AUTHOR), Chan, Gallant Kar-Lun4,5 (AUTHOR) gallant@gallantbiotech.com, Hu, Wei-Hui1,2 (AUTHOR) huweihui@scau.edu.cn
Publikováno v:
Chinese Medicine. 9/9/2024, Vol. 19 Issue 1, p1-19. 19p.
Autor:
Correia, Cláudia1 (AUTHOR) alejandro.hidalgogon@mcri.edu.au, Christoffersson, Jonas1 (AUTHOR), Tejedor, Sandra1,2 (AUTHOR), El-Haou, Saïd3 (AUTHOR), Matadamas-Guzman, Meztli1 (AUTHOR), Nair, Syam1 (AUTHOR), Dönnes, Pierre2,4 (AUTHOR), Musa, Gentian1 (AUTHOR), Rohman, Mattias5 (AUTHOR), Sundqvist, Monika1 (AUTHOR), Riddle, Rebecca B.1,6 (AUTHOR), Nugraha, Bramasta1 (AUTHOR), Bellido, Ioritz Sorzabal7 (AUTHOR), Johansson, Markus2 (AUTHOR), Wang, Qing-Dong1 (AUTHOR), Hidalgo, Alejandro1,8 (AUTHOR), Jennbacken, Karin1 (AUTHOR), Synnergren, Jane2,9 (AUTHOR), Später, Daniela1,8 (AUTHOR) claudia.correia@astrazeneca.com
Publikováno v:
Cells (2073-4409). Aug2024, Vol. 13 Issue 16, p1339. 29p.
Autor:
Jo H; SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea., Park JH; SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.; Department of Nano Science and Technology, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea., Choi D; SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.; Department of Nano Science and Technology, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea., Kim K; SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.; Department of Nano Science and Technology, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea., An S; SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.; Department of Nano Science and Technology, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.; Department of Nano Engineering, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.; Department of Semiconductor Convergence Engineering, Sungkyunkwan University (SKKU), Suwon, 16419, Republic of Korea.
Publikováno v:
Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Aug 13, pp. e2407719. Date of Electronic Publication: 2024 Aug 13.
Autor:
Sun N; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States., Ning B; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States., Hansson KM; Bioscience Heart Failure Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Bruce AC; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States., Seaman SA; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States., Zhang C; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States., Rikard M; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States., DeRosa CA; Department of Chemistry, University of Virginia, Charlottesville, Virginia, 22904, United States., Fraser CL; Department of Chemistry, University of Virginia, Charlottesville, Virginia, 22904, United States., Wågberg M; Bioscience Heart Failure Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Fritsche-Danielson R; Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Wikström J; Bioscience Heart Failure Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Chien KR; Integrated Cardiometabolic Center, Karolinska Institute, SE-141 52, Huddinge, Sweden.; Department of Cell and Molecular Biology and Medicine, Karolinska Institute, SE-171 77, Stockholm, Sweden., Lundahl A; Department of Drug Metabolism and Pharmacokinetics Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Hölttä M; Safety & ADME Translational Sciences, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Carlsson LG; Bioscience Heart Failure Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Peirce SM; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States. smp6p@virginia.edu., Hu S; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22908, United States. songhu@virginia.edu.
Publikováno v:
Scientific reports [Sci Rep] 2018 Nov 30; Vol. 8 (1), pp. 17509. Date of Electronic Publication: 2018 Nov 30.
Autor:
Giordanetto F; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Knerr L; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Nordberg P; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Pettersen D; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Selmi N; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Beisel HG; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., de la Motte H; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Månsson Å; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Dahlström M; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Broddefalk J; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Saarinen G; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Klingegård F; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Hurt-Camejo E; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Rosengren B; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Wikström J; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Wågberg M; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Brengdahl J; Reagents and Assay Development, Mechanistic Biology and Profiling, and Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Rohman M; Reagents and Assay Development, Mechanistic Biology and Profiling, and Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Sandmark J; Reagents and Assay Development, Mechanistic Biology and Profiling, and Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Åkerud T; Reagents and Assay Development, Mechanistic Biology and Profiling, and Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Roth RG; Reagents and Assay Development, Mechanistic Biology and Profiling, and Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Jansen F; Reagents and Assay Development, Mechanistic Biology and Profiling, and Structure and Biophysics, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden., Ahlqvist M; Medicinal Chemistry, Translational Sciences, Bioscience, and Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg SE-431 89, Sweden.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2018 Jun 23; Vol. 9 (7), pp. 600-605. Date of Electronic Publication: 2018 Jun 23 (Print Publication: 2018).